We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · May 27, 2022

Prevalence and Prognostic Significance of DNMT3A- and TET2-Clonal Haematopoiesis–Driver Mutations in Patients With STEMI



Additional Info

Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
EBioMedicine 2022 Apr 01;78(April)103964, S Wang, S Hu, X Luo, X Bao, J Li, M Liu, Y Lv, C Zhao, M Zeng, X Chen, A Unsworth, S Jones, TW Johnson, SJ White, H Jia, B Yu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading